Australia, March 27 -- Janssen Pharmaceutica N.V., owns the trademark (2561723) for 'CAPLYMA' till June 30, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use.]
Type of Mark: Word
Date of Acceptance: Jan. 19
Registration Advertised: March 26
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2561723.
Disclaimer: Curated by HT Syndication.
